Shanghai Toong Yeuan Food Technology will represent Wellmune WGP, the industry leading immune health ingredient from Biothera that is clinically proven to boost the performance of key immune cells that help keep the body healthy. Nine clinical studies support the safety and efficacy of Wellmune WGP, a beta 1,3/1,6 glucan from a proprietary strain of baker’s yeast.
“Shanghai Toong Yeuan specializes in the sale of proprietary ingredients that are backed by credible science,” said Richard Mueller, chief executive officer of Biothera. “This focus, along with their well-established relationships with major food, beverage and supplement companies in China, makes Shanghai Toong Yeuan an excellent representative for Wellmune in this important market.”
“We are excited about the strong scientific evidence, safety and efficacy behind Wellmune WGP,” said David Wang, Chairman of Shanghai Toong Yeuan Food Technology. “We are confident that this ingredient has the potential to greatly contribute to the wellness of the people of China.”
Shanghai Toong Yeuan Food Technology Co., Ltd. will participate in Food Ingredients China on March 26-28 in Shanghai. The company will sponsor a seminar on the morning of Tuesday, March 26 during which John Blocher, Ph.D., assistant vice president for Research & Development at Biothera, will discuss science of Wellmune WGP and present clinical research results with this unique ingredient. FI China is one of the most specialized trade events for food ingredients and additives in China, attracting more than 800 exhibitors.
